Vitrebond™ for Tooth Pulp Exposure

SB
PM
Overseen ByPaula Myhre, MS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a dental treatment called Vitrebond™ Pulp Protect Liner/Base, designed to protect the inner part of a tooth (the pulp) when exposed. The trial aims to assess the safety and effectiveness of this treatment for individuals with permanent teeth that have pulp exposure due to cavities, injuries, or other accidents. Participants should have at least one permanent tooth requiring a specific dental procedure called direct pulp capping. Individuals with a small pulp exposure in a permanent tooth may be suitable for this study. As an unphased trial, this study offers a unique opportunity to contribute to dental research and potentially benefit from an innovative treatment.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you have a history of chronic use of anti-inflammatory, pain, or mind-altering drugs, you may not be eligible to participate.

What prior data suggests that Vitrebond™ Pulp Protect Liner/Base is safe for direct pulp capping?

Research has shown that Vitrebond™ Pulp Protect Liner/Base has been tested for safety in dental work, but not specifically for covering exposed dental pulp. Some sources advise against its direct use on exposed pulp. While the product may be safe for certain dental applications, more research is needed to confirm its safety for this specific purpose.

Studies have not reported any serious side effects, indicating it is generally well-tolerated in dental procedures. However, since this trial tests the product for a new use, its safety for covering exposed pulp remains under investigation. Participants should consider this when deciding whether to join the trial.12345

Why are researchers excited about this trial?

Vitrebond™ Pulp Protect Liner/Base is unique because it offers a new approach for direct pulp capping, which is a technique used to protect exposed tooth pulp. Unlike traditional materials like calcium hydroxide or mineral trioxide aggregate, Vitrebond™ uses a light-cured resin-modified glass ionomer that bonds directly to the tooth structure. This bonding capability helps seal the pulp from bacterial infiltration more effectively. Researchers are excited because this could lead to better long-term protection and faster pulp healing.

What evidence suggests that Vitrebond™ might be an effective treatment for tooth pulp exposure?

Research has shown that Vitrebond™, a special dental material, can be effective for direct pulp capping (DPC). It can replace calcium hydroxide, commonly used to protect the soft tissue inside a tooth. In this trial, participants will receive Vitrebond™ Pulp Protect Liner/Base for direct pulp capping. Dentists apply Vitrebond™ to cover and shield the exposed pulp, which can result from cavities or injury. Its effectiveness in maintaining tooth health makes it a promising choice for DPC. Vitrebond™ hardens when exposed to light, simplifying its use for dentists. Overall, it provides a reliable way to protect the inside of a tooth when exposed.678910

Who Is on the Research Team?

MS

Mabi Singh, DMD, BDS, MS

Principal Investigator

Tufts University

Are You a Good Fit for This Trial?

This trial is for individuals with permanent teeth that have pulp exposure due to deep cavities, trauma, or other causes. Participants must need direct pulp capping (DPC), a procedure to preserve tooth health when the dental pulp is exposed.

Inclusion Criteria

I can understand and sign the consent form, or my legal representative can.
Subject is in good general health (i.e., meets American Society of Anesthesiologists (ASA) Level I or ASA Level II classification criteria)
Subject is able and willing to follow study restrictions
See 10 more

Exclusion Criteria

Study tooth exhibits bleeding of the exposed pulp that does not stop within 8 minutes
My tooth is diagnosed with cracked tooth syndrome.
My study tooth cannot be fixed.
See 12 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Solventum™ Vitrebond™ Pulp Protect Liner/Base for direct pulp capping on permanent teeth with pulp exposure

1 day
1 visit (in-person)

Follow-up

Participants are monitored for pulp vitality and other dental health indicators post-restoration

5 years
Scheduled visits at 3 months, 6 months, 1 year, and annually up to 5 years

What Are the Treatments Tested in This Trial?

Interventions

  • Vitrebond™ Pulp Protect Liner/Base
Trial Overview The study tests Solventum™ Vitrebond™ Pulp Protect Liner/Base's safety and effectiveness as a treatment for DPC in teeth with exposed pulps. It aims to see if this liner/base can help maintain the health of affected teeth.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Vitrebond™ Pulp Protect Liner/BaseExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Solventum US LLC

Lead Sponsor

Trials
68
Recruited
10,600+

Bryan Hanson

Solventum US LLC

Chief Executive Officer since 2024

Bachelor's degree in Business Administration from Indiana University

Dr. Ryan Egeland

Solventum US LLC

Chief Medical Officer

MD, trained in Plastic and Reconstructive Surgery

Citations

Clinical Study Evaluating Solventum™ Vitrebond™ Pulp ...This research study is looking at the safety and effectiveness of Solventum™ Vitrebond™ Pulp Protect Liner/Base for direct pulp capping ...
The effect of different pulp capping methods on ...Abstract. Background. To evaluate the intra-pulpal temperature during different direct pulp capping methods and light-cured procedures.
Study to evaluate the Efficacy of Resin-modified Glass ...Conclusion: This study shows that Vitrebond™ (3M ESPE) light-cured resin-modified glass ionomer liner can be used as an alternative to calcium ...
Study to evaluate the Efficacy of Resin-modified Glass ...This study shows that Vitrebond™ (3M ESPE) light-cured resin-modified glass ionomer liner can be used as an alternative to calcium hydroxide as a direct ...
Comparison of CaOH with MTA for Direct Pulp CappingBased on previous work on pulp capping with CaOH, showing annual failure rates ranging from 5% to 21% (Fitzgerald and Heys, 1991; Matsuo et al., 1996; Clement ...
Clinical Study Evaluating Solventum™ Vitrebond™ Pulp ...The purpose of this clinical study will be to assess the effectiveness and safety of Vitrebond™ Pulp Protect for direct pulp capping on ...
Vitrebond™CONTRAINDICATIONS. Pulp Protection: Vitrebond liner/base is not indicated for direct pulp capping. If a pulp exposure occurs, cover the exposure with a calcium ...
3m™ vitrebond™ liner/baseVitrebond Liner/Base is not indicated for direct pulp capping. If a pulp exposure occurs, cover the exposure with a calcium hydroxide material. Place the ...
February 6, 2023 3M ESPE Dental Products Prithul Bom Most ...Liner/base, Pulp capping. Liner, Pulp capping agent. Vitrebond Plus liner/base is indicated for lining and basing applications under the.
Vitrebond Plus Technical Product ProfilePulp Protection: Vitrebond Plus liner/base is not indicated for direct pulp capping. If a pulp exposure has occurred and if the situation warrants a direct pulp ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security